Overexpressed GFPT2 has been detected in cancer-associated fibroblasts in lung adenocarcinoma and, specifically, regulates metabolic reprogramming in this NSCLC subtype (Zhang et al., 2018). The gene discussed is GFPT2; the disease is non-small cell lung carcinoma.